The Department of Energy, with “low confidence,” says SARS-CoV-2 may have come from a lab, and a controversial doctors groups touts ivermectin for the flu and RSV.
Quick takes: New SARS-CoV-2 lab leak assessment, claims for ivermectin benefit beyond COVID
More from COVID-19More posts in COVID-19 »
- Quick takes: School infection prevention, low US respiratory virus levels, polio in 3 nations
- Study: Kids with long COVID have impaired exercise capacity
- Global meta-analysis estimates 43% rate of multidrug resistance in COVID patients
- COVID-19 linked to increased preterm birth, other problems in pregnancy